Loading…
Lobbying Spend
—
Filings
136
Firms Hired
4
Active Period
2010–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models); drug pricing; H.R.6130, Alzheimers Screening and Prevention (ASAP) Act of 2025.
Client expense: — · Firm income: $50,000
Matched citations: H.R.6130
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: H.R.8800
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.4784
Bipartisan Health Care Act
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.891
National Defense Authorization Act for Fiscal Year 2026
2026 · second_quarter · Firm: ROBERTI ASSOCIATES CONSULTING, LLC
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.
Client expense: — · Firm income: $50,000
Matched citations: S. 2296
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to tax reform; R&D tax credit; Section 899; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: H.R.8800
National Defense Authorization Act for Fiscal Year 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.4784
Bipartisan Health Care Act
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act (H.R.8800/S.4784); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.891
National Defense Authorization Act for Fiscal Year 2026
2026 · first_quarter · Firm: ROBERTI ASSOCIATES CONSULTING, LLC
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.
Client expense: — · Firm income: $50,000
Matched citations: S. 2296
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to tax reform; R&D tax credit; Section 899; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Bipartisan Health Care Act
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.891
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: ROBERTI ASSOCIATES CONSULTING, LLC
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.
Client expense: — · Firm income: $50,000
Matched citations: S. 2296
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838/P.L.119-60); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3838
National Defense Authorization Act for Fiscal Year 2026
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838/P.L.119-60); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.2296
Bipartisan Health Care Act
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838/P.L.119-60); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.891
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
H.R.1, One Big Beautiful Bill Act (P.L.119-21), all bio-pharmaceutical related provisions.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to tax reform; R&D tax credit; Section 899; H.R.1, One Big Beautiful Bill Act (P.L.119-21).
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3838
National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.2296
Bipartisan Health Care Act
2025 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; pharmaceutical scheduling; TRICARE coverage issues in FY2026 National Defense Authorization Act (S.2296/H.R.3838); PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Client expense: — · Firm income: $50,000
Matched citations: S.891
National Defense Authorization Act for Fiscal Year 2026
2025 · third_quarter · Firm: ROBERTI ASSOCIATES CONSULTING, LLC
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.
Client expense: — · Firm income: $50,000
Matched citations: S. 2296
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
H.R.1, One Big Beautiful Bill Act, all bio-pharmaceutical related provisions.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Issues related to tax reform; R&D tax credit; Section 899; H.R.1, One Big Beautiful Bill Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1
Source: Senate LDA